Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8021342 | 1.00 | ALDH1A1 (0.42) | ALDH1A1 | |
| Cyclohexane SCHEMBL29153241 | 0.98 | ALDH1A1 (0.46) | ALDH1A1 | |
| SCHEMBL11426532 | 0.90 | ALDH1A1 (0.40) | ALDH1A1 | |
| SCHEMBL48400 | 0.87 | ALDH1A1 (0.37) | ALDH1A1 | |
| SCHEMBL20484233 | 0.84 | ALDH1A1 (0.40) | ALDH1A1 | |
| SCHEMBL11422745 | 0.82 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL29124327 | 0.78 | ALDH1A1 (0.36) | ALDH1A1 | |
| SCHEMBL330951 | 0.76 | ALDH1A1 (0.39) | ALDH1A1 | |
| SCHEMBL8007242 | 0.75 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL8007238 | 0.75 | ALDH1A1 (0.32) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117500782-A | Process for preparing at least one polyisocyanate | 巴斯夫欧洲公司 | 2024-02-02 | — | — | CN | disclosed |
| EP-3728238-A1 | SULPHONYL UREA DERIVATIVES AS NLRP3 INFLAMMASOME MODULATORS | Nodthera Limited (GB) | 2020-10-28 | — | — | EP | disclosed |
| US-20040259888-A1 | Novel 4-aminofuropyrimidines and the use thereof | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2004-12-23 | — | — | US | disclosed |
| EP-1425283-A1 | NOVEL 4-AMINOFUROPYRIMIDINES AND THE USE THEREOF | Bayer HealthCare AG (DE) | 2004-06-09 | — | — | EP | disclosed |
| WO-2003018589-A1 | NOVEL 4-AMINOFUROPYRIMIDINES AND THE USE THEREOF | BAYER HEALTHCARE AG (DE) | 2003-03-06 | — | — | WO | disclosed |
| EP-0800512-B1 | ANTIHERPES PEPTIDOMIMETIC COMPOUNDS | BOEHRINGER INGELHEIM CA LTD (CA) | 2000-01-05 | — | — | EP | disclosed |
| US-5846941-A | Isosteric antiherpes peptide derivatives II | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 1998-12-08 | — | — | US | disclosed |
| EP-0800512-A1 | ANTIHERPES PEPTIDOMIMETIC COMPOUNDS | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 1997-10-15 | — | — | EP | disclosed |
| WO-1996020171-A1 | ANTIHERPES PEPTIDOMIMETIC COMPOUNDS | BOEHRINGER INGELHEIM (CANADA) LTD./BOEHRINGER INGELHEIM (CANADA) LTÉE (CA) | 1996-07-04 | — | — | WO | disclosed |
| US-4510097-A | Hindered aliphatic monoisocyanates | W. R. GRACE & CO. (US) | 1985-04-09 | — | — | US | disclosed |
| US-4211847-A | CYCLOHEXYL ISOTHIOCYANATE OR HINDERED CYCLOALIPHATIC ISOCYANATE | W. R. GRACE & CO. (US) | 1980-07-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040259888-A1 | Novel 4-aminofuropyrimidines and the use thereof | DPYD, TPMT, TYMP | ALDH1A1 176/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.